Trial CTRI/2020/04/024775
Publication Agarwal A, medRxiv, 2020
Primary outcome on the report: The primary outcome of the study was a composite measure of progress to severe disease (PaO2/FiO2 ratio <100) any time within 28 days of enrolment or all-cause mortality at 28 days.